Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:e85
doi: 10.1161/01.CIR.0000064680.19579.1E
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marfella, R.
Right arrow Articles by Moye, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marfella, R.
Right arrow Articles by Moye, L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes Complications
*Heart Attack
*Heart Failure
Related Collections
Right arrow Remodeling
Right arrow Type 2 diabetes
Right arrow Acute myocardial infarction
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2003;107:e85.)
© 2003 American Heart Association, Inc.


Correspondence

Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction

Raffaele Marfella, MD; Mario Verza, MD; Dario Giugliano, MD

Department of Geriatrics and Metabolic Diseases, Second University of Naples, Napoli, Italy, raffaele.marfella@unina2.it

To the Editor:

Scott D. Solomon and colleagues1 report that the increased incidence of heart failure (HF) after myocardial infarction (MI) in patients with diabetes cannot be explained by an increased propensity for left ventricular enlargement. Although HF develops at twice the rate in diabetic patients than in nondiabetic patients after MI, and although the development of HF is associated with increased ventricular enlargement in both groups, the incidence and extent of left ventricular (LV) enlargement are significantly less in diabetic patients. Increased risk of HF in diabetes without MI is associated with poor glycemic control, neurohormonal activation, and increased oxidative stress.2 Studies have identified dyssynchrony between right and left ventricular contraction and relaxation as independent predictor of HF and cardiac mortality in patients with HF.3,4 The sequelae of ventricular dyssynchrony include loss of coordination of contraction and relaxation, leading to increases in regional and global wall stress, reductions in stroke volume and in the rate of rise of left ventricular pressure, diminished diastolic filling time, prolongation of mitral regurgitation, and diminished effective ejection time.

We evaluated whether abnormalities of echocardiographic parameters of ventricular dyssynchrony were associated with differences in glycemic control in 31 type 2 diabetic patients (16 men and 15 women) aged 59.2±8.7 years (mean±SD) 97±19 days after uncomplicated first MI. Myocardial performance index, transmitral Doppler flow, and pulmonary venous flow analysis were performed to assess ventricular dyssynchrony. Compared with patients without ventricular dyssynchrony (n=17), patients with ventricular dyssynchrony (n=14) had increased HbA1c levels (7.2±1.7% versus 9.8±1.2%, P<0.01) and fasting plasma glucose (7.7±1.1 versus 8.9±1.3 mmol/L, P<0.02), whereas body mass index, duration of diabetes, and use of ß-blocker therapy were similar in both groups. Moreover, echocardiographic determination of LV areas, infarct segment length, and ejection fractions showed no difference between the groups. Echocardiographic parameters for ventricular dyssynchrony might be seen as an early indicator of left ventricular dysfunction in diabetic patients after MI, particularly in those with poor glycemic control.

References

  1. Solomon SD, St John Sutton M, Lamas GA, et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation. 2002; 106: 1251–1255.[Abstract/Free Full Text]
  2. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001; 103: 2668–2673.[Abstract/Free Full Text]
  3. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997; 95: 2660–2667.[Abstract/Free Full Text]
  4. Xiao HB, Roy C, Fujimoto S, et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol. 1996; 53: 163–170.[CrossRef][Medline] [Order article via Infotrieve]

 

Response

Scott D. Solomon, MD; Hicham Skali, MD; Eugene Braunwald, MD; Marc A. Pfeffer, MD, PhD, For the Survival And Ventricular Enlargement (SAVE) Investigators

Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Boston, Mass

Martin St. John Sutton, MD; Ted Plappert

Cardiovascular Division, University of Pennsylvania, Philadelphia, Pa

Gervasio A. Lamas, MD

Division of Cardiology, Mt Sinai Medial Center, Miami Beach, Fla

Jean L. Rouleau, MD

Cardiovascular Division, University of Toronto Health Network, Toronto, Ontario

Lemuel Moye, PhD

School of Public Health, University of Texas, Houston, Tex

Marfella et al have suggested an alternative mechanism by which diabetes may modify ventricular remodeling. In a small number of type 2 diabetics, they have shown that worsening measures of diabetes, including glucose intolerance and HbA1c, were associated with ventricular dyssynchrony. These data raise the possibility that ventricular dyssynchrony might further distinguish diabetics from non-diabetics and might influence ventricular remodeling after myocardial infarction. Unfortunately, we have no specific data to support this hypothesis from the Survival And Ventricular Enlargement (SAVE) trial patients presented in our analysis.1 Specifically, we have not looked at measures of dyssynchrony, either echocardiographic or electrocardiographic, and do not have fasting plasma glucose levels or HbA1c levels for these patients. Nevertheless, the fact that diabetics developed heart failure after myocardial infarction at twice the incidence of non-diabetics while not demonstrating increased ventricular remodeling argues that inherent functional abnormalities, including possibly ventricular dyssynchrony, likely contribute to these differences. Assessment of these and other functional differences between diabetics and non-diabetics is worthy of further investigation.

References

  1. Solomon SD, St John Sutton M, Lamas GA, et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation. 2002; 106: 1251–1255.[Abstract/Free Full Text]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marfella, R.
Right arrow Articles by Moye, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marfella, R.
Right arrow Articles by Moye, L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes Complications
*Heart Attack
*Heart Failure
Related Collections
Right arrow Remodeling
Right arrow Type 2 diabetes
Right arrow Acute myocardial infarction
Right arrow Lipid and lipoprotein metabolism